A Canadian Study of Persistence on Ofatumumab Using Patient Support Program Data

Exclusion Criteria

• •Patients were excluded if they met any of the criteria below:
• •Patients with no demographic information
• •Patients who could not be linked across the data sources required for analysis (Kesimpta Go Program Enrollment Form, Pharmacy Claims Forms, Kesimpta Go Program Database)
• •Patients with 3+ treatment interruptions (patient was "on hold" - i.e., not currently receiving the treatment in the patient support program)